A Study of Teduglutide (Revestive®) in Participants With Short Bowel Syndrome (SBS) in Canada

Clinical trial NCT05371028 · COMPLETED

Trial details

NCT number: NCT05371028
Sponsor: Takeda
Status: COMPLETED
Study type: OBSERVATIONAL

Short Bowel Syndrome (SBS)

Start date: 2023-09-23
Primary completion: 2025-02-19
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.